About 2 results found for searched term "Orantinib" (0.29 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2153 | Orantinib | VEGFR/PDGFR |
| SU6668; TSU-68 | ||
| Orantinib (SU6668; TSU-68) is a protein kinase inhibitor of PDGF-Rβ, VEGF-R2 and FGF-R1 with IC50 of 0.06, 2.4 and 3.0 μM, respectively. | ||
| M57222 | (Z)-Orantinib | VEGFR/PDGFR |
| (Z)-Orantinib ((Z)-SU6668) is a potent, selective, orally active and ATP competitive inhibitor of Flk‐1/KDR, PDGFRβ, and FGFR1, with IC50s of 2.1, 0.008, and 1.2 µM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
